Phytotherapy in Inflammatory Lung Diseases: An Emerging Therapeutic Interventional Approach

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Phytochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/978-981-13-6920-9_18
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Important and specific role for basophils in acute allergic reactions

  2018cited by this paper
• What national and subnational interventions and policies based on Mediterranean and Nordic diets are recommended or implemented in the WHO European Region, and is there evidence of effectiveness in reducing noncommunicable diseases?

  2018cited by this paper
• Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study.

  2018cited by this paper
• Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease

  2018cited by this paper
• Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol

  2018cited by this paper
• Epithelial‐Derived Cytokines in Asthma

  2017cited by this paper
• Role of Proteases in Chronic Obstructive Pulmonary Disease

  2017cited by this paper
• Sputum colour can identify patients with neutrophilic inflammation in asthma

  2017cited by this paper
• Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD)

  2017cited by this paper
• Sputum basophils are increased in eosinophilic asthma compared with non‐eosinophilic asthma phenotypes

  2017cited by this paper
• Natural history of COPD: gaps and opportunities

  2017cited by this paper
• Airway basophils are increased and activated in eosinophilic asthma

  2017cited by this paper
• The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.

  2016cited by this paper
• Anticancer Efficacy of Polyphenols and Their Combinations

  2016cited by this paper
• Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases

  2016cited by this paper
• Flavonoids: an overview

  2016cited by this paper
• Does Protease-Antiprotease Imbalance Explain Chronic Obstructive Pulmonary Disease?

  2016cited by this paper
• Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.

  2016cited by this paper
• Burden of chronic obstructive pulmonary disease: healthcare costs and beyond.

  2015cited by this paper
• Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation

  2015cited by this paper
• Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer

  2015cited by this paper
• Callicarpa japonica Thunb. attenuates cigarette smoke-induced neutrophil inflammation and mucus secretion.

  2015cited by this paper
• Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.

  2015cited by this paper
• Global burden of asthma among children.

  2014cited by this paper
• Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications

  2014cited by this paper
• Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP)

  2014cited by this paper
• Phytochemical analysis and evaluation of leaf and root parts of the medicinal herb, Hypochaeris radicata L. for in vitro antioxidant activities.

  2014cited by this paper
• Inflammatory Signalings Involved in Airway and Pulmonary Diseases

  2013cited by this paper
• National Center for Complementary and Alternative Medicine (NCCAM) Introduction to Acupuncture with Disclaimer

  2013cited by this paper
• Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model

  2013cited by this paper
• Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers

  2012cited by this paper
• Cysteinyl leukotriene receptors, old and new; implications for asthma

  2012cited by this paper
• Asthma and Chronic Obstructive Pulmonary Disease (COPD) – Differences and Similarities

  2012cited by this paper
• Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality

  2012cited by this paper
• Herbal Formula, PM014, Attenuates Lung Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• Kaempferol and Kaempferol Rhamnosides with Depigmenting and Anti-Inflammatory Properties

  2011cited by this paper
• The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.

  2011cited by this paper
• Similarities and differences in inflammatory mechanisms of asthma and COPD

  2011cited by this paper
• Beta-Adrenergic Agonists

  2010cited by this paper
• Health need and the use of alternative medicine among adults who do not use conventional medicine

  2010cited by this paper
• The role of the epithelium in airway remodeling in asthma.

  2009cited by this paper
• Immunologic aspects of chronic obstructive pulmonary disease.

  2009cited by this paper
• Diagnosis of asthma in adults

  2009cited by this paper
• Bronchial asthma: diagnosis and long-term treatment in adults.

  2008cited by this paper
• Global strategy for asthma management and prevention: GINA executive summary

  2008cited by this paper
• Immunology of asthma and chronic obstructive pulmonary disease

  2008cited by this paper
• Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People

  2008cited by this paper
• Targeting eosinophils in asthma.

  2008cited by this paper
• Chronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic

  2007cited by this paper
• Chronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Aspects on pathophysiological mechanisms in COPD

  2007cited by this paper
• Fracture risk with intermittent high-dose oral glucocorticoid therapy.

  2007cited by this paper
• Antioxidant therapies in COPD

  2006cited by this paper
• Inflammatory subtypes in asthma: Assessment and identification using induced sputum

  2006cited by this paper
• Inflammatory cells in the airways in COPD

  2006cited by this paper
• Anticholinergic agents in asthma and COPD.

  2006cited by this paper
• Aging Biology and Geriatric Clinical Pharmacology

  2004cited by this paper
• Knowledge and practice of complementary medicine amongst public primary care clinic doctors in Kinta district, Perak.

  2004cited by this paper
• Eosinophils and interleukin-5: the debate continues.

  2003cited by this paper
• Methylxanthines for exacerbations of chronic obstructive pulmonary disease.

  2003cited by this paper
• New concepts in chronic obstructive pulmonary disease.

  2003cited by this paper
• Chronic obstructive pulmonary disease: molecular and cellularmechanisms

  2003cited by this paper
• Mast-cell infiltration of airway smooth muscle in asthma.

  2002cited by this paper
• Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species.

  2002cited by this paper
• 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease.

  2002cited by this paper
• Overcoming barriers to nonadherence in asthma treatment.

  2002cited by this paper
• Traditional/complementary medicine: the way ahead.

  2002cited by this paper
• Asthma and COPD: Basic Mechanisms and Clinical Management

  2002cited by this paper
• Pathogenesis of fibrosis: role of TGF-beta and CTGF.

  2002cited by this paper
• Complementary Therapies For Pharmacists

  2001cited by this paper
• Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis.

  2001cited by this paper
• Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.

  1999cited by this paper
• Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.

  1999cited by this paper
• Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

  1998cited by this paper
• Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

  1998cited by this paper
• Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma.

  1995cited by this paper
• Pharmacotherapy: A pathophysiologic approach

  1992cited by this paper
• Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

  1992cited by this paper
• Theophylline toxicity: clinical features of 116 consecutive cases.

  1990cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Lung inflammation: normal host defense or a complication of some diseases?

  1987cited by this paper

• Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma

  2022cites this paper
• Plant-Based Chemical Moieties for Targeting Chronic Respiratory Diseases

  2021cites this paper
• Celastrol-loaded liquid crystalline nanoparticles as an anti-inflammatory intervention for the treatment of asthma

  2020cites this paper